Evidence map›Paper›PMID 33125603›Full record

ArticleArchivum immunologiae et therapiae experimentalis2020

A Proliferation-Inducing Ligand Regulation in Polymorphonuclear Neutrophils by Panax ginseng.

Wioletta Ratajczak-Wrona, Natalia Wawrusiewicz-Kurylonek, Marzena Garley, Adam Jacek Kretowski, Ewa Jablonska

Open access · hybridAbstract read
In one paragraph

Article in Archivum immunologiae et therapiae experimentalis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Wioletta Ratajczak-WronaDepartment of Immunology, Medical University of Bialystok, J. Waszyngtona 15A, 15-269, Bialystok, Poland. wioletta.ratajczak-wrona@umb.edu.pl.ORCID http://orcid.org/0000-0002-7634-0875
Natalia Wawrusiewicz-KurylonekDepartment of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland.ORCID http://orcid.org/0000-0002-1087-8154
Marzena GarleyDepartment of Immunology, Medical University of Bialystok, J. Waszyngtona 15A, 15-269, Bialystok, Poland.ORCID http://orcid.org/0000-0002-6727-3850
Adam Jacek KretowskiDepartment of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland.ORCID http://orcid.org/0000-0002-4522-4978
Ewa JablonskaDepartment of Immunology, Medical University of Bialystok, J. Waszyngtona 15A, 15-269, Bialystok, Poland.ORCID http://orcid.org/0000-0001-7899-7830
Medical University of Białystok · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A proliferation-inducing ligand (APRIL) is a member of the tumor necrosis factor superfamily that was first identified as a factor favoring tumorigenesis. APRIL is important fitness and survival factors for B cells and plasma cells in the periphery. Considering this, as well as the quantitative predominance of neutrophils among the peripheral blood leukocytes, we carried out the first study assessing the influence of the transforming growth factor (TGF)-β signaling pathway on APRIL expression in these cells. Furthermore, as the Rb1 ginsenoside is known to exhibit multiple pharmacological activities, we verified if the saponin is capable of modulating the process. The present study shows that TGF-β increased the expression of APRIL and the level of phospho-p38, phospho-Akt(T308), and phospho-Akt(S473) in the cytoplasmic fraction, as well as the expression of Fra1, c-Fos, and c-Jun in the nuclear fraction, of neutrophils. However, exposure of these cells to Rb1 reduced the expression and level of the investigated proteins. No changes were found in the expression of APRIL and the level of p-p38 in the cytoplasmic fraction of neutrophils following the application of Rb1 alone, as well as in the neutrophils incubated first with Rb1 and then with TGF-β, whereas a higher level of phosphorylation was observed for Akt and PI3 kinases in the cells. Moreover, a higher expression of all the studied transcription factors was observed in the nuclear fraction of neutrophils. Based on the observed changes, it may be assumed that the expression of APRIL molecule in TGF-β-induced neutrophils and its regulation by Rb1 are associated with PI3K/AKT signaling pathways and transcription factors Fra-1, Fra-2, c-Jun, and c-Fos. Rb1 appears to be a favorable factor that may be potentially used in the modulation of tumor-promoting APRIL expression.

Indexed as

Cells, CulturedFos-Related Antigen 1Gene Expression RegulationGinsenosidesHealthy VolunteersHumansLeukocytes, MononuclearMaleNeutrophilsp38 Mitogen-Activated Protein KinasesPanaxPhosphatidylinositol 3-KinasesPhosphorylationProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-fosSignal TransductionFos-Related Antigen 1ginsenoside Rb1Ginsenosidesp38 Mitogen-Activated Protein KinasesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-fosTransforming Growth Factor betaTumor Necrosis Factor Ligand Superfamily Member 13APRILGinsenoside Rb1Neutrophilsp38PI3K/AktTGF-β

Identifiers

PMID33125603
PMCPMC7599173
OpenAlexW3096174433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.